相关实验视频
Updated: Jan 16, 2026

05:18
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
1.3K
大量减肥患者的手臂轮:一篇文学评论
Atiyeh Bishara1, Rawad Chalhoub1, Edwin Chrabieh2
1From the Division of Plastic, Reconstructive and Aesthetic surgery, American University of Beirut, Beirut, Lebanon.
Plastic and reconstructive surgery. Global open
|September 26, 2025
概括
对于大量体重减轻的患者来说,抽脂辅助腕整形术与逐步方法相结合可能提供最好的结果. 这种技术旨在获得最佳的美学效果,患者的满意度,并在手臂升高手术后减少痕.
科学领域:
- 整形外科 整形外科 整形外科
- 腹部外科手术的结果
- 整形外科美容手术 整形外科美容手术
背景情况:
- 许多手臂整形技术存在,但对于大量减肥患者的最佳方法没有共识.
- 患者安全,审美效果,痕质量和满意度是关键考虑因素.
研究的目的:
- 确定能产生最佳审美效果和痕质量的手臂整形技术.
- 确定患者满意度最高,痕可见度最低以及 Post-bariatric 患者并发症率最低的方法.
主要方法:
- 在PubMed,Embase和Web of Science上使用PICO方法进行了全面的文献搜索.
- 包括自1974年以来发表的临床队列研究,重点关注接受手臂整形手术的病患.
主要成果:
- 审查了15项研究,分析了两种主要方法:整体切切除术和吸脂辅助腕整形术.
- 切割手臂整形与更高的整体并发症率有关.
- 报告了两个主要的痕位置:中间和后中间,有变化.
结论:
- 每种手臂整形技术都有明显的优点和缺点.
- 建议结合抽脂辅助腕整形术和逐步"随时切割"的方法.
- 这种综合方法可能会导致更安全的手术,最佳的美学效果,并减少并发症.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
247
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
247
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169

